logo
#

Latest news with #MethyleneBlueInjection

Nexus Pharmaceuticals Launches Methylene Blue Injection
Nexus Pharmaceuticals Launches Methylene Blue Injection

Yahoo

time22-05-2025

  • Business
  • Yahoo

Nexus Pharmaceuticals Launches Methylene Blue Injection

LINCOLNSHIRE, Ill., May 22, 2025--(BUSINESS WIRE)--Nexus Pharmaceuticals, LLC proudly announces the launch of Methylene Blue Injection, USP. Methylene Blue Injection is indicated for the treatment of methemoglobinemia – a condition that affects the blood's ability to carry oxygen. "The launch represents a vital addition to Nexus' growing portfolio of life-saving and difficult-to-manufacture medications," said Usman Ahmed, CEO of Nexus Pharmaceuticals. "Methylene Blue is a critical drug in emergency care, and we're proud to contribute to the FDA-approved supply." Nexus' Methylene Blue is available in cartons of five, single-dose 10 mL vials (5 mg/mL) (0.5%). Order through your Wholesaler or from Customer Service at (888) 806-4606. Unit of Sale NDC: 14789-0119-05 - Cencora – 10299117- Cardinal – 5982525- McKesson – 3029428- Morris & Dickson – 609628 About Nexus Pharmaceuticals, LLC: Nexus Pharmaceuticals, LLC, a US-based healthcare company, specializes in innovative processes to make difficult-to-manufacture specialty and generic drugs that are easier to use, less labor intensive, and more streamlined in practice. Nexus ensures that its high-quality drug products fulfill a critical unmet medical need and deliver dependable life-saving treatment options when and where they're needed most. View source version on Contacts Media Contact: Grace Conroygconroy@ (847) 527-7490

Nexus Pharmaceuticals Launches Methylene Blue Injection
Nexus Pharmaceuticals Launches Methylene Blue Injection

Business Wire

time22-05-2025

  • Business
  • Business Wire

Nexus Pharmaceuticals Launches Methylene Blue Injection

LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--Nexus Pharmaceuticals, LLC proudly announces the launch of Methylene Blue Injection, USP. Methylene Blue Injection is indicated for the treatment of methemoglobinemia – a condition that affects the blood's ability to carry oxygen. 'The launch represents a vital addition to Nexus' growing portfolio of life-saving and difficult-to-manufacture medications,' said Usman Ahmed, CEO of Nexus Pharmaceuticals. 'Methylene Blue is a critical drug in emergency care, and we're proud to contribute to the FDA-approved supply.' Nexus' Methylene Blue is available in cartons of five, single-dose 10 mL vials (5 mg/mL) (0.5%). Order through your Wholesaler or from Customer Service at (888) 806-4606. Unit of Sale NDC: 14789-0119-05 - Cencora – 10299117 - Cardinal – 5982525 - McKesson – 3029428 - Morris & Dickson – 609628 About Nexus Pharmaceuticals, LLC: Nexus Pharmaceuticals, LLC, a US-based healthcare company, specializes in innovative processes to make difficult-to-manufacture specialty and generic drugs that are easier to use, less labor intensive, and more streamlined in practice. Nexus ensures that its high-quality drug products fulfill a critical unmet medical need and deliver dependable life-saving treatment options when and where they're needed most.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store